Scandent Imaging Ltd operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Scandent Imaging Ltd with three other
pharmaceutical manufacturers in Asia:
Malaysian Genomics Resource Centre Berhad
sales of 27.73 million Malaysian Ringgits [US$6.63 million]
Thyrocare Technologies Ltd
(4.03 billion Indian Rupees [US$56.37 million]
of which 91%
was Diagnostic Testing Services), and
Medinova Diagnostic Services Ltd
(89.73 million Indian Rupees [US$1.26 million]
Sales increased substantially in 2019:
During the year ended March of 2019, sales at
Scandent Imaging Ltd were 141.89 million Indian Rupees (US$1.99 million).
increase of 173.5%
versus 2018, when the company's sales were 51.88 million Indian Rupees.
This was the fifth consecutive year of sales increases at Scandent Imaging Ltd
(and since 2014, sales have increased a total of 105,790%).